Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

J App Pharm Sci. 2015; 5(8): 147-151


Radioprotective Properties of Chitosan on Cultured Human Lymphocytes against Electron Beam Radiation

Shama Rao, Sukanya Shetty, Suchetha Kumari Nalilu, L N Madhu.




Abstract

The radioprotective effects of naturally occurring compounds have been investigated in vitro and in vivo considering their pharmacological role in prevention and treatment of cancer. Chitosan (CS) is a naturally occurring polymer that has been increasing attention in pharmaceutical and biomedical applications because of its biocompatibility, biodegradability, nontoxicity, cationic properties and bio adhesive characters. Lymphocytes were treated with different concentrations of chitosan for 2, 4, 6 and 24 hr periods. Cell viability was determined by tryphan blue dye exclusion assay, single strand DNA damage by alkaline comet assay and in vitro cytogenetic damages were evaluated by micronucleus assays. Treatment of lymphocytes with chitosan before and after the exposure to 4Gy of electron beam radiation (EBR) resulted in the reduction of percentage of tail DNA in comet from 24.06±3.92 to 6.94±1.34 and olive tail moment (OTM) was reduced from 25.34±3.09 to 10.66±0.23 at 10µg/mL concentration. The micronucleus formation in radiation control group (13.75±0.37) was significantly reduced in chitosan pretreated groups 7.63±1.02. Cells treated with chitosan at 10µg/mL showed maximum viability after exposure to EBR. Present investigation data proves the protective effect of CS against EBR induced damage in lymphocyte. However, increase in concentration above 100 µg/mL though resulted in higher protection, an increased cell toxicity was also noticed.

Key words: Radioprotection, Electron Beam Radiation, Chitosan






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.